Patients with infectious mononucleosis should not be prescribed amoxicillin. Instead, supportive treatment is recommended for their care.

Understanding Infectious Mononucleosis

Infectious mononucleosis, also known as glandular fever, is a viral infection caused by the Epstein-Barr virus (EBV) in 90% of cases. It is most commonly seen in adolescents and young adults. The classic triad of symptoms includes sore throat, pyrexia, and lymphadenopathy, which are present in around 98% of patients. Other symptoms include malaise, anorexia, headache, palatal petechiae, splenomegaly, hepatitis, lymphocytosis, haemolytic anaemia, and a maculopapular rash. The symptoms typically resolve after 2-4 weeks.

The diagnosis of infectious mononucleosis is confirmed through a heterophil antibody test (Monospot test) in the second week of the illness. Management is supportive and includes rest, drinking plenty of fluids, avoiding alcohol, and taking simple analgesia for any aches or pains. It is recommended to avoid playing contact sports for 4 weeks after having glandular fever to reduce the risk of splenic rupture.

Interestingly, there is a correlation between EBV and socioeconomic groups. Lower socioeconomic groups have high rates of EBV seropositivity, having frequently acquired EBV in early childhood when the primary infection is often subclinical. However, higher socioeconomic groups show a higher incidence of infectious mononucleosis, as acquiring EBV in adolescence or early adulthood results in symptomatic disease.

On the day of surgery, it is recommended to omit the morning dose of gliclazide for patients taking sulfonylureas. However, if the patient takes BD, they can have the afternoon dose. Metformin should be taken as usual on the day before and on the day of elective surgery, except for lunchtime dose if taken three times a day.

Preparation for surgery varies depending on whether the patient is undergoing an elective or emergency procedure. For elective cases, it is important to address any medical issues beforehand through a pre-admission clinic. Blood tests, urine analysis, and other diagnostic tests may be necessary depending on the proposed procedure and patient fitness. Risk factors for deep vein thrombosis should also be assessed, and a plan for thromboprophylaxis formulated. Patients are advised to fast from non-clear liquids and food for at least 6 hours before surgery, and those with diabetes require special management to avoid potential complications. Emergency cases require stabilization and resuscitation as needed, and antibiotics may be necessary. Special preparation may also be required for certain procedures, such as vocal cord checks for thyroid surgery or bowel preparation for colorectal cases.

Keratitis, which is likely caused by contact lens wear, is characterized by a red eye, sensitivity to light, and a feeling of grittiness. Episcleritis typically does not cause pain or light sensitivity. Blepharitis is inflammation of the eyelid and does not typically result in light sensitivity. Conjunctivitis usually causes minimal pain or light sensitivity.

Understanding Keratitis: Inflammation of the Cornea

Keratitis is a condition that refers to the inflammation of the cornea. While conjunctivitis is a common eye infection that is not usually serious, microbial keratitis can be sight-threatening and requires urgent evaluation and treatment. The causes of keratitis can vary, with bacterial infections typically caused by Staphylococcus aureus and Pseudomonas aeruginosa commonly seen in contact lens wearers. Fungal and amoebic infections can also cause keratitis, with acanthamoebic keratitis accounting for around 5% of cases. Parasitic infections such as onchocercal keratitis can also cause inflammation of the cornea.

Other factors that can cause keratitis include viral infections such as herpes simplex keratitis, environmental factors like photokeratitis (e.g. welder’s arc eye), and exposure keratitis. Clinical features of keratitis include a red eye with pain and erythema, photophobia, a foreign body sensation, and the presence of hypopyon. Referral is necessary for contact lens wearers who present with a painful red eye, as an accurate diagnosis can only be made with a slit-lamp examination.

Management of keratitis involves stopping the use of contact lenses until symptoms have fully resolved, as well as the use of topical antibiotics such as quinolones. Cycloplegic agents like cyclopentolate can also be used for pain relief. Complications of keratitis can include corneal scarring, perforation, endophthalmitis, and visual loss. Understanding the causes and symptoms of keratitis is important for prompt diagnosis and treatment to prevent serious complications.

Treatment Options for Guillain-Barré Syndrome

Guillain–Barré syndrome (GBS) is an autoimmune disorder that affects the peripheral nerves, resulting in symmetrical weakness, hyporeflexia, and paraesthesia. The condition often occurs after an infection, usually involving the respiratory or gastrointestinal tract. The most commonly used treatment for GBS is intravenous immunoglobulin (IVIG), which helps to reduce the severity and duration of symptoms. Plasmapheresis (plasma exchange) is another option that filters antibodies from the patient’s plasma.

However, corticosteroids such as intravenous prednisolone have not been shown to improve GBS symptoms and may even prolong recovery. Haemodialysis is not necessary unless the patient has concurrent renal failure. Antivirals such as intravenous acyclovir have no role in managing GBS as it is not a viral illness. Although a bacterial infection may precede GBS, antibiotics such as intravenous ceftriaxone are not used to treat the autoimmune process causing the neurological symptoms. In some cases, patients with GBS may require invasive ventilation, which may cause pneumonia and require treatment with antibiotics.

Probability of Inheriting Sickle Cell Disease

Sickle cell anaemia is an autosomal recessive condition that affects the haemoglobin in red blood cells. If one parent has sickle cell anaemia (HbSS) and the other is a carrier (HbAS), the baby has a 1 in 2 chance of inheriting the condition. The baby will inherit the HbS allele from the mother and either the HbA or HbS allele from the father, resulting in possible genotypes of HbAS, HbSS, HbAS, or HbSS. This gives the baby a 1 in 2 chance of having sickle cell disease and a 1 in 2 chance of being a carrier.

If both parents are carriers (HbAS), the baby has a 1 in 4 chance of inheriting sickle cell disease. If one parent has the condition and the other is a carrier, there is a 1 in 2 chance the child will inherit the condition. In the case of a heterozygous father and a mother with sickle cell disease, there is a 1 in 3 chance of the baby having the condition. Finally, if both parents are carriers and the baby inherits one HbS allele from each parent, there is a 1 in 8 chance of the baby having sickle cell disease and a 3 in 8 chance of being a carrier. Understanding the probabilities of inheriting sickle cell disease can help individuals make informed decisions about family planning and genetic testing.

Patients with symptoms of pulmonary embolism, such as chest pain and shortness of breath, are typically treated for 3 months if the PE is provoked. This is especially true for patients who have had recent surgery, as they are at a higher risk for a provoked PE. Clinical signs of a PE include tachycardia, hypoxia, and an elevated D-dimer. ECG changes may include sinus tachycardia, S1Q3T3, and T-wave inversion in the right-sided leads. Patients with right heart strain may also have raised troponin levels. The treatment of choice for a provoked PE is a low-molecular-weight heparin or a direct oral anticoagulant. Apixaban for 6 months is used for unprovoked PEs without risk factors, while apixaban for 12 months is not routinely prescribed. Dual antiplatelet therapy is used for coronary ischaemia, but a raised D-dimer, hypoxia, and ECG changes suggest a PE is more likely.

Management of Pulmonary Embolism: NICE Guidelines

Pulmonary embolism (PE) is a serious condition that requires prompt management. The National Institute for Health and Care Excellence (NICE) updated their guidelines on the management of venous thromboembolism (VTE) in 2020, with some key changes. One of the significant changes is the recommendation to use direct oral anticoagulants (DOACs) as the first-line treatment for most people with VTE, including those with active cancer. Another change is the increasing use of outpatient treatment for low-risk PE patients, determined by a validated risk stratification tool.

Anticoagulant therapy is the cornerstone of VTE management, and the guidelines recommend using apixaban or rivaroxaban as the first-line treatment following the diagnosis of a PE. If neither of these is suitable, LMWH followed by dabigatran or edoxaban or LMWH followed by a vitamin K antagonist (VKA) can be used. For patients with active cancer, DOACs are now recommended instead of LMWH. The length of anticoagulation is determined by whether the VTE was provoked or unprovoked, with treatment typically stopped after 3-6 months for provoked VTE and continued for up to 6 months for unprovoked VTE.

In cases of haemodynamic instability, thrombolysis is recommended as the first-line treatment for massive PE with circulatory failure. Patients who have repeat pulmonary embolisms, despite adequate anticoagulation, may be considered for inferior vena cava (IVC) filters. However, the evidence base for IVC filter use is weak.

Overall, the updated NICE guidelines provide clear recommendations for the management of PE, including the use of DOACs as first-line treatment and outpatient management for low-risk patients. The guidelines also emphasize the importance of individualized treatment based on risk stratification and balancing the risks of VTE recurrence and bleeding.

Azithromycin or erythromycin are appropriate options for treating Chlamydia in a pregnant patient who is allergic to penicillin. In this case, the patient’s NAAT testing confirmed the presence of Chlamydia, but doxycycline is contraindicated due to the patient’s pregnancy. Amoxicillin is not an option due to the patient’s penicillin allergy. Ceftriaxone is not indicated for Chlamydia, and doxycycline is contraindicated in pregnancy. Therefore, azithromycin or erythromycin are the most appropriate treatment options.

Chlamydia is a common sexually transmitted infection caused by Chlamydia trachomatis. It is prevalent in the UK, with approximately 1 in 10 young women affected. The incubation period is around 7-21 days, but many cases are asymptomatic. Symptoms in women include cervicitis, discharge, and bleeding, while men may experience urethral discharge and dysuria. Complications can include epididymitis, pelvic inflammatory disease, and infertility.

Traditional cell culture is no longer widely used for diagnosis, with nuclear acid amplification tests (NAATs) being the preferred method. Testing can be done using urine, vulvovaginal swab, or cervical swab. Screening is recommended for sexually active individuals aged 15-24 years, and opportunistic testing is common.

Doxycycline is the first-line treatment for Chlamydia, with azithromycin as an alternative if doxycycline is contraindicated or not tolerated. Pregnant women may be treated with azithromycin, erythromycin, or amoxicillin. Patients diagnosed with Chlamydia should be offered partner notification services, with all contacts since the onset of symptoms or within the last six months being notified and offered treatment.

Understanding the Side Effects of Amiodarone: A Comprehensive Overview

Amiodarone is a medication commonly used to treat cardiac arrhythmias. However, it is important to be aware of its potential side effects. Here is a breakdown of some of the most important things to know:

Hyperthyroidism: Amiodarone can cause both hypo and hyperthyroidism. Patients taking this medication should have their thyroid function checked regularly.

COPD: While amiodarone is not known to cause COPD, it can lead to pulmonary toxicity, including pneumonitis and fibrosis. Patients should have yearly chest x-rays.

Drug-induced diabetes mellitus: There is no known association between amiodarone and the development of diabetes mellitus.

Drug-induced pemphigus: Long-term use of amiodarone can cause phototoxicity and skin discoloration. Patients should protect their skin from light during treatment. However, it is not known to cause drug-induced pemphigus.

Renal calculi: There is no known association between amiodarone and the development of kidney disease, including renal calculi.

Other important side effects of amiodarone include hepatotoxicity, bradycardia, phototoxicity, and development of corneal deposits. If you are taking amiodarone, it is important to be aware of these potential side effects and to discuss any concerns with your healthcare provider.

The symptoms of pruritus and pain that gradually worsen, along with the results of the examination, indicate a high likelihood of post-thrombotic syndrome.

Post-Thrombotic Syndrome: A Complication of Deep Vein Thrombosis

Post-thrombotic syndrome is a clinical syndrome that may develop following a deep vein thrombosis (DVT). It is caused by venous outflow obstruction and venous insufficiency, which leads to chronic venous hypertension. Patients with post-thrombotic syndrome may experience painful, heavy calves, pruritus, swelling, varicose veins, and venous ulceration.

In the past, compression stockings were offered to patients with DVT to reduce the risk of post-thrombotic syndrome. However, current recommendations state that elastic graduated compression stockings should not be used to prevent post-thrombotic syndrome or VTE recurrence after a proximal DVT. This recommendation does not cover the use of elastic stockings for the management of leg symptoms after DVT.

Once post-thrombotic syndrome has developed, compression stockings are a recommended treatment. Other recommendations include keeping the leg elevated. It is important for healthcare providers to recognize the potential complications of DVT and to provide appropriate management to prevent the development of post-thrombotic syndrome.

Due to his history of bladder cancer and obesity, pioglitazone is not recommended and contraindicated. Instead, sitagliptin, a DPP-4 inhibitor, is the most suitable option. Exenatide, which typically leads to weight loss, is beneficial for obese individuals with diabetes, but it does not meet the NICE criteria for body mass index of 35 kg/m².

NICE updated its guidance on the management of type 2 diabetes mellitus (T2DM) in 2022, reflecting advances in drug therapy and improved evidence regarding newer therapies such as SGLT-2 inhibitors. The first-line drug of choice remains metformin, which should be titrated up slowly to minimize gastrointestinal upset. HbA1c targets should be agreed upon with patients and checked every 3-6 months until stable, with consideration for relaxing targets on a case-by-case basis. Dietary advice includes encouraging high fiber, low glycemic index sources of carbohydrates and controlling intake of foods containing saturated fats and trans fatty acids. Blood pressure targets are the same as for patients without type 2 diabetes, and antiplatelets should not be offered unless a patient has existing cardiovascular disease. Only patients with a 10-year cardiovascular risk > 10% should be offered a statin, with atorvastatin 20mg as the first-line choice.

Sulphonylureas possess the characteristic of enhancing the secretion of insulin produced naturally within the body.

Metformin is a medication commonly used to treat type 2 diabetes mellitus. It belongs to a class of drugs called biguanides and works by activating the AMP-activated protein kinase (AMPK), which increases insulin sensitivity and reduces hepatic gluconeogenesis. Additionally, it may decrease the absorption of carbohydrates in the gastrointestinal tract. Unlike other diabetes medications, such as sulphonylureas, metformin does not cause hypoglycemia or weight gain, making it a first-line treatment option, especially for overweight patients. It is also used to treat polycystic ovarian syndrome and non-alcoholic fatty liver disease.

While metformin is generally well-tolerated, gastrointestinal side effects such as nausea, anorexia, and diarrhea are common and can be intolerable for some patients. Reduced absorption of vitamin B12 is also a potential side effect, although it rarely causes clinical problems. In rare cases, metformin can cause lactic acidosis, particularly in patients with severe liver disease or renal failure. However, it is important to note that lactic acidosis is now recognized as a rare side effect of metformin.

There are several contraindications to using metformin, including chronic kidney disease, recent myocardial infarction, sepsis, acute kidney injury, severe dehydration, and alcohol abuse. Additionally, metformin should be discontinued before and after procedures involving iodine-containing x-ray contrast media to reduce the risk of contrast nephropathy.

When starting metformin, it is important to titrate the dose slowly to reduce the incidence of gastrointestinal side effects. If patients experience intolerable side effects, modified-release metformin may be considered as an alternative.

Understanding the Glasgow Coma Scale for Adults

The Glasgow Coma Scale (GCS) is a tool used to assess the level of consciousness in adults who have suffered a brain injury or other neurological condition. It is based on three components: motor response, verbal response, and eye opening. Each component is scored on a scale from 1 to 6, with a higher score indicating a better level of consciousness.

The motor response component assesses the patient’s ability to move in response to stimuli. A score of 6 indicates that the patient is able to obey commands, while a score of 1 indicates no movement at all.

The verbal response component assesses the patient’s ability to communicate. A score of 5 indicates that the patient is fully oriented, while a score of 1 indicates no verbal response at all.

The eye opening component assesses the patient’s ability to open their eyes. A score of 4 indicates that the patient is able to open their eyes spontaneously, while a score of 1 indicates no eye opening at all.

The GCS score is expressed as a combination of the scores from each component, with the motor response score listed first, followed by the verbal response score, and then the eye opening score. For example, a GCS score of 13, M5 V4 E4 at 21:30 would indicate that the patient had a motor response score of 5, a verbal response score of 4, and an eye opening score of 4 at 9:30 PM.

Overall, the Glasgow Coma Scale is a useful tool for healthcare professionals to assess the level of consciousness in adults with neurological conditions.

In the case of pulseless electrical activity, which is a non-shockable rhythm, the ALS algorithm requires the administration of adrenaline as soon as intravascular access is achieved. This should be done immediately after the rhythm check, following two more minutes of CPR. The recommended dose is 1mg IV, which should be repeated every 3-5 minutes. It is important to note that intramuscular adrenaline is not appropriate for cardiac arrest, and IV amiodarone is not indicated for non-shockable rhythms. While it is correct to avoid shocking the patient, it is incorrect to delay drug administration until the next rhythm check. The most recent Resuscitation Council Guidelines (2021) support the immediate administration of adrenaline in non-shockable rhythms.

The 2015 Resus Council guidelines for adult advanced life support outline the steps to be taken when dealing with patients with shockable and non-shockable rhythms. For both types of patients, chest compressions are a crucial part of the process, with a ratio of 30 compressions to 2 ventilations. Defibrillation is recommended for shockable rhythms, with a single shock for VF/pulseless VT followed by 2 minutes of CPR. Adrenaline and amiodarone are the drugs of choice for non-shockable rhythms, with adrenaline given as soon as possible and amiodarone administered after 3 shocks for VF/pulseless VT. Thrombolytic drugs should be considered if a pulmonary embolus is suspected. Atropine is no longer recommended for routine use in asystole or PEA. Oxygen should be titrated to achieve saturations of 94-98% following successful resuscitation. The Hs and Ts should be considered as potential reversible causes of cardiac arrest.

Understanding SIADH: The Syndrome of Inappropriate Antidiuretic Hormone Secretion

SIADH, or the syndrome of inappropriate antidiuretic hormone secretion, is a condition where the body produces too much vasopressin (ADH), leading to overhydration in both the intracellular and extracellular compartments. This can result in dilutional hyponatraemia, where the sodium concentration falls to dangerous levels. Symptoms may include drowsiness, lethargy, irritability, mental confusion, and disorientation, with seizures and coma being the most severe features.

SIADH can develop as a paraneoplastic syndrome, most commonly in patients with small-cell carcinoma of the lung. However, it can also be associated with various other neoplastic and non-neoplastic pathologies, as well as certain medications. Treatment for SIADH may involve restriction of fluids, demeclocycline, or other interventions, but caution must be taken to avoid complications such as cardiac failure, cerebral oedema, or central pontine myelinolysis.

While a sodium-restricted diet or sodium-reduced water drinking may contribute to hyponatraemia, they are unlikely to cause such severe levels in the absence of other medical conditions. Liver metastases and bone metastases may also be associated with hyponatraemia, but in the context of a known diagnosis of small-cell lung cancer, SIADH is the most likely explanation.

Overall, understanding SIADH and its potential causes and treatments is crucial for managing hyponatraemia and preventing serious complications.

NICE recommends using the CHA2DS2-VASc score to determine the need for anticoagulation in patients with any history of AF. The ORBIT scoring system should be used to assess bleeding risk, but anticoagulation should not be withheld solely on the grounds of age or risk of falls. DOACs are now recommended as the first-line anticoagulant for patients with AF, with warfarin used second-line if a DOAC is contraindicated or not tolerated. Aspirin is not recommended for reducing stroke risk in patients with AF.

Understanding Parkinsonism and Its Causes

Parkinsonism is a term used to describe a group of neurological disorders that share similar symptoms with Parkinson’s disease. The causes of Parkinsonism can vary, with some cases being drug-induced, such as the use of antipsychotics or metoclopramide. Other causes include progressive supranuclear palsy, multiple system atrophy, Wilson’s disease, post-encephalitis, and dementia pugilistica, which is often seen in individuals who have suffered from chronic head trauma, such as boxers. Additionally, exposure to toxins like carbon monoxide or MPTP can also lead to Parkinsonism.

It is important to note that not all medications that cause extra-pyramidal side-effects will lead to Parkinsonism. For example, domperidone does not cross the blood-brain barrier and therefore does not cause these side-effects. Understanding the various causes of Parkinsonism can help with early diagnosis and treatment, as well as prevention in some cases. By identifying the underlying cause, healthcare professionals can tailor treatment plans to address the specific needs of each patient.

The management of tuberculosis has been outlined in guidelines by the British Thoracic Society. It is recommended that liver function tests are conducted in all cases and monitored during treatment. Prior to starting ethambutol, it is important to check visual acuity and renal function.

Side-Effects and Mechanism of Action of Tuberculosis Drugs

Rifampicin is a drug that inhibits bacterial DNA dependent RNA polymerase, which prevents the transcription of DNA into mRNA. However, it is a potent liver enzyme inducer and can cause hepatitis, orange secretions, and flu-like symptoms.

Isoniazid, on the other hand, inhibits mycolic acid synthesis. It can cause peripheral neuropathy, which can be prevented with pyridoxine (Vitamin B6). It can also cause hepatitis and agranulocytosis. Additionally, it is a liver enzyme inhibitor.

Pyrazinamide is converted by pyrazinamidase into pyrazinoic acid, which in turn inhibits fatty acid synthase (FAS) I. However, it can cause hyperuricaemia, leading to gout, as well as arthralgia, myalgia, and hepatitis.

Lastly, Ethambutol inhibits the enzyme arabinosyl transferase, which polymerizes arabinose into arabinan. It can cause optic neuritis, so it is important to check visual acuity before and during treatment. Additionally, the dose needs adjusting in patients with renal impairment.

In summary, these tuberculosis drugs have different mechanisms of action and can cause various side-effects. It is important to monitor patients closely and adjust treatment accordingly to ensure the best possible outcomes.

Effects of Cortisol on the Body: Misconceptions and Clarifications

Cortisol, a hormone produced by the adrenal glands, plays a crucial role in regulating various bodily functions. However, there are some misconceptions about the effects of cortisol on the body. Here are some clarifications:

Hirsutism: Elevated cortisol levels can cause a condition called Cushingoid, which may result in hirsutism in women. This is characterized by excessive hair growth in areas such as the face, chest, and back.

Hypoglycemia: Contrary to popular belief, cortisol does not cause hypoglycemia. Instead, it increases gluconeogenesis (the production of glucose from non-carbohydrate sources) and reduces glucose uptake in peripheral tissues, resulting in hyperglycemia.

Enhanced glucose uptake: Cortisol actually has the opposite effect on glucose uptake. It reduces the uptake of glucose into peripheral tissues and accelerates gluconeogenesis.

Hypotension: Patients with adrenal hyperfunction (excessive cortisol production) often suffer from hypertension (high blood pressure), not hypotension (low blood pressure). This is because excessive mineralocorticoids are released, which can cause fluid retention and increase blood pressure.

Hypocalciuria: Cortisol can lead to osteopenia and osteoporosis by increasing bone breakdown. This may result in hypercalcemia (high levels of calcium in the blood), which can cause hypercalciuria (excessive calcium in the urine), not hypocalciuria.

Haemolytic uraemic syndrome (HUS) is a condition characterized by the simultaneous occurrence of microangiopathic haemolytic anaemia, thrombocytopenia, and acute kidney injury. This set of blood tests shows all three of these symptoms, indicating a possible diagnosis of HUS. HUS is most commonly found in children, with 90% of cases caused by Shiga toxin-producing E. coli. However, a patient with normal renal function and high platelet count is unlikely to have HUS, as low platelet count is a typical symptom. If a patient has ongoing diarrhoea or vomiting due to E. coli infection, they may require intravenous fluids to support their renal function. A raised haemoglobin level is not expected in HUS, as patients usually have reduced haemoglobin due to microangiopathic haemolytic anaemia. Additionally, HUS typically causes thrombocytopenia, not high platelet count. In some cases, children with HUS may require platelet transfusion.

Distant abscesses can be caused by infective embolic plaques in patients with infective endocarditis, including brain abscesses. To aid in the diagnosis of infective endocarditis, an echocardiogram is the most appropriate next investigation for this patient, given their examination findings. While a CT of the chest and abdomen may be necessary if the underlying cause remains unknown, it is less important with a normal chest radiograph and abdominal examination. Bronchoscopy, lower limb imaging, and EEG are not currently necessary.

Understanding Brain Abscesses

Brain abscesses can occur due to various reasons such as sepsis from middle ear or sinuses, head injuries, and endocarditis. The symptoms of brain abscesses depend on the location of the abscess, with those in critical areas presenting earlier. Brain abscesses can cause a considerable mass effect in the brain, leading to raised intracranial pressure. Symptoms of brain abscesses include dull and persistent headaches, fever, focal neurology, nausea, papilloedema, and seizures.

To diagnose brain abscesses, doctors may perform imaging with CT scanning. Treatment for brain abscesses involves surgery, where a craniotomy is performed to remove the abscess cavity. However, the abscess may reform because the head is closed following abscess drainage. Intravenous antibiotics such as 3rd-generation cephalosporin and metronidazole are also administered. Additionally, intracranial pressure management with dexamethasone may be necessary.

Overall, brain abscesses are a serious condition that requires prompt medical attention. Understanding the symptoms and treatment options can help individuals seek medical help early and improve their chances of recovery.

For patients with an acute ischaemic stroke who present within 4.5 hours, the recommended treatment is a combination of thrombolysis and thrombectomy. Thrombolysis involves the use of alteplase, a tissue plasminogen activator that breaks down the clot, while thrombectomy physically removes the clot using a specialized device inserted through the femoral artery. In this case, as the patient has confirmed occlusion of the proximal anterior circulation, both thrombolysis and thrombectomy should be performed together for the best possible outcome. While alteplase alone can be considered if thrombectomy is not available, a better prognosis is more likely with the combination treatment. It would not be appropriate to perform thrombectomy alone without considering thrombolysis, as the patient is presenting within the window for thrombolysis and should be considered for both in combination according to the guidelines.

The Royal College of Physicians (RCP) and NICE have published guidelines on the diagnosis and management of patients following a stroke. The management of acute stroke includes maintaining normal levels of blood glucose, hydration, oxygen saturation, and temperature. Blood pressure should not be lowered in the acute phase unless there are complications. Aspirin should be given as soon as possible if a haemorrhagic stroke has been excluded. Anticoagulants should not be started until brain imaging has excluded haemorrhage. Thrombolysis with alteplase should only be given if administered within 4.5 hours of onset of stroke symptoms and haemorrhage has been definitively excluded. Mechanical thrombectomy is a new treatment option for patients with an acute ischaemic stroke. NICE recommends thrombectomy for people who have acute ischaemic stroke and confirmed occlusion of the proximal anterior circulation demonstrated by computed tomographic angiography or magnetic resonance angiography. Secondary prevention includes the use of clopidogrel and dipyridamole. Carotid artery endarterectomy should only be considered if carotid stenosis is greater than 70% according to ECST criteria or greater than 50% according to NASCET criteria.

Common Side Effects of Antiepileptic Drugs

Antiepileptic drugs are commonly used to treat seizures and epilepsy. However, they can also cause various side effects. Here are some of the common side effects of the most commonly used antiepileptic drugs:

Phenytoin: This drug can cause fatigue, bony tenderness, paraesthesiae, and gingival hypertrophy. Patients should maintain good oral hygiene to minimize this problem. Megaloblastic anemia is a rare but possible side effect.

Phenobarbital: This drug can cause fatigue, bony tenderness, and paraesthesiae. However, it is not associated with gingival hypertrophy. Megaloblastic anemia is a common side effect, which can be treated with folic acid.

Primidone: This drug is metabolized to phenobarbital, so its side effects are similar to those of phenobarbital. Drowsiness, visual disturbances, headache, and dizziness are the most common ones. Plasma concentrations of the derived phenobarbital should be monitored for optimum response dosing.

Sodium valproate: This drug can cause nausea, drowsiness, dizziness, vomiting, and general weakness. Rare but serious side effects include thrombocytopenia, hepatotoxicity, and pancreatitis. Treatment should be withdrawn immediately if there are signs of hepatic dysfunction or pancreatitis.

Carbamazepine: This drug is associated with blood dyscrasias. Rarely, there are major effects of aplastic anemia and agranulocytosis, but more commonly, they are minor changes limited to decreased white cell count and thrombocytopenia. Regular monitoring of blood counts and hepatic and renal function is recommended. It also carries an increased risk of hyponatremia and syndrome of inappropriate antidiuretic hormone secretion.

Common Side Effects of Antiepileptic Drugs

Treatment Options for Kawasaki Disease: Understanding the Use of Aspirin

Kawasaki disease is a condition that affects children and causes inflammation in the blood vessels throughout the body. When diagnosed, treatment typically involves intravenous immunoglobulin and aspirin. In this article, we will discuss the use of aspirin in the treatment of Kawasaki disease and why it is important.

Oral aspirin is given to patients with Kawasaki disease due to its anti-inflammatory and antiplatelet properties. It helps to reduce the chances of blood clots if there are developing problems in the heart, such as coronary artery aneurysms that can occur in Kawasaki disease. The dosage of aspirin is usually higher (30 mg/kg per day) for up to two weeks and then continued at lower doses (3-5 mg/kg per day) until a review of echocardiogram, which is usually 6-8 weeks after the onset of illness.

If the review echocardiogram at 6-8 weeks shows no evidence of any coronary artery aneurysms, then aspirin is usually stopped. However, until that time, patients with Kawasaki disease will continue to take oral aspirin daily.

It is important to note that other non-steroidal anti-inflammatory medications such as ibuprofen should be avoided while taking aspirin. Additionally, oral steroids are a second-line treatment that are considered when there is failure to respond to initial intravenous immunoglobulin therapy.

In conclusion, aspirin is an important part of the treatment for Kawasaki disease due to its anti-inflammatory and antiplatelet properties. Patients with Kawasaki disease will continue to take oral aspirin daily until a review echocardiogram shows no evidence of any coronary artery aneurysms. It is important to follow the treatment plan prescribed by a specialist to ensure the best possible outcome for the patient.

When a couple is trying to conceive, it is normal for it to take up to one year for them to be successful. Therefore, medical examinations are typically conducted after one year of consistent attempts to conceive. However, it may be wise to address any physical barriers that could be hindering the couple’s ability to conceive, which is why their sexual history is taken into consideration.

Infertility is a common issue that affects approximately 1 in 7 couples. It is important to note that around 84% of couples who have regular sexual intercourse will conceive within the first year, and 92% within the first two years. The causes of infertility can vary, with male factor accounting for 30%, unexplained causes accounting for 20%, ovulation failure accounting for 20%, tubal damage accounting for 15%, and other causes accounting for the remaining 15%.

When investigating infertility, there are some basic tests that can be done. These include a semen analysis and a serum progesterone test. The serum progesterone test is done 7 days prior to the expected next period, typically on day 21 for a 28-day cycle. The interpretation of the serum progesterone level is as follows: if it is less than 16 nmol/l, it should be repeated and if it remains consistently low, referral to a specialist is necessary. If the level is between 16-30 nmol/l, it should be repeated, and if it is greater than 30 nmol/l, it indicates ovulation.

It is important to counsel patients on lifestyle factors that can impact fertility. This includes taking folic acid, maintaining a healthy BMI between 20-25, and advising regular sexual intercourse every 2 to 3 days. Additionally, patients should be advised to quit smoking and limit alcohol consumption to increase their chances of conceiving.

Understanding Psoriatic Arthritis and Differential Diagnosis

Psoriatic arthritis is a type of inflammatory arthritis that is associated with psoriasis. It is classified as one of the seronegative spondyloarthropathies and can present in various ways, including symmetric polyarthritis, asymmetrical oligo-arthritis, sacroiliitis, distal interphalangeal joint disease, and arthritis mutilans. It affects both men and women equally, and around 10-20% of patients with psoriasis develop psoriatic arthritis.

When considering a differential diagnosis, osteoarthritis is unlikely in this age group, and the presence of a raised estimated sedimentation rate and fatigue in the absence of trauma suggests an inflammatory process. Gout often affects the first metatarsophalangeal joint of the first toe, while rheumatoid arthritis can also affect women of this age group, but psoriatic arthritis is more likely if the patient has dactylitis and a first-degree relative with psoriasis. Systemic lupus erythematosus can also affect women of this age group, but again, psoriatic arthritis is more likely if dactylitis and a first-degree relative with psoriasis are present.

In conclusion, understanding the presentation and differential diagnosis of psoriatic arthritis is crucial for accurate diagnosis and appropriate management.

The primary way in which Nexplanon works is by preventing ovulation.

Implanon and Nexplanon are subdermal contraceptive implants that slowly release the progestogen hormone etonogestrel to prevent ovulation and thicken cervical mucus. Nexplanon is the newer version and has a redesigned applicator to prevent deep insertions and is radiopaque for easier location. It is highly effective with a failure rate of 0.07/100 women-years and lasts for 3 years. It does not contain estrogen, making it suitable for women with a past history of thromboembolism or migraine. It can be inserted immediately after a termination of pregnancy. However, a trained professional is needed for insertion and removal, and additional contraceptive methods are required for the first 7 days if not inserted on days 1 to 5 of a woman’s menstrual cycle.

The main disadvantage of these implants is irregular and heavy bleeding, which can be managed with a co-prescription of the combined oral contraceptive pill. Other adverse effects include headache, nausea, and breast pain. Enzyme-inducing drugs such as certain antiepileptic and rifampicin may reduce the efficacy of Nexplanon, and women should switch to a method unaffected by enzyme-inducing drugs or use additional contraception until 28 days after stopping the treatment.

There are also contraindications for using these implants, such as ischaemic heart disease/stroke, unexplained, suspicious vaginal bleeding, past breast cancer, severe liver cirrhosis, and liver cancer. Current breast cancer is a UKMEC 4 condition, which represents an unacceptable risk if the contraceptive method is used. Overall, these implants are a highly effective and long-acting form of contraception, but they require careful consideration of the potential risks and contraindications.

Causes of Hearing Loss in Adults: Understanding the Differences

As we age, our hearing abilities may decline, leading to a condition known as presbyacusis. This age-related hearing loss affects high-frequency sounds and can be detected through an audiogram that shows reduced hearing for both air and bone conduction at higher frequencies in the affected ear.

Another cause of hearing loss is otosclerosis, which is a form of conductive hearing loss caused by problems with the ossicular chain. An audiogram would show a wide air-bone gap, indicating a gap between the hearing level for both air and bone conduction.

While multiple sclerosis can cause sensorineural hearing loss in adults, it is a rare occurrence and not the most likely option in most cases. Barotrauma, on the other hand, is a conductive cause of hearing loss that can lead to drum perforation. An audiogram would show a wide air-bone gap on the affected ear.

Ménière’s disease is another cause of sensorineural hearing loss, but it is less common than presbyacusis. It typically presents with symptoms of tinnitus, vertigo, and a fullness in the ear. Infections such as measles and mumps, or ototoxic medications, would usually present earlier. Barotrauma and otosclerosis are causes of conductive deafness.

In summary, understanding the differences between these various causes of hearing loss can help individuals and healthcare professionals identify the most likely cause and determine the appropriate treatment plan.

The routine use of non-invasive ventilation in asthmatics is not supported by current guidelines.

Management of Acute Asthma

Acute asthma is classified by the British Thoracic Society (BTS) into three categories: moderate, severe, and life-threatening. Patients with any of the life-threatening features should be treated as having a life-threatening attack. A fourth category, Near-fatal asthma, is also recognized. Further assessment may include arterial blood gases for patients with oxygen saturation levels below 92%. A chest x-ray is not routinely recommended unless the patient has life-threatening asthma, suspected pneumothorax, or failure to respond to treatment.

Admission criteria include a previous near-fatal asthma attack, pregnancy, an attack occurring despite already using oral corticosteroid, and presentation at night. All patients with life-threatening asthma should be admitted to the hospital, and patients with features of severe acute asthma should also be admitted if they fail to respond to initial treatment. Oxygen therapy should be started for hypoxaemic patients. Bronchodilation with short-acting beta₂-agonists (SABA) is recommended, and all patients should be given 40-50mg of prednisolone orally daily. Ipratropium bromide and IV magnesium sulphate may also be considered for severe or life-threatening asthma. Patients who fail to respond require senior critical care support and should be treated in an appropriate ITU/HDU setting. Criteria for discharge include stability on discharge medication, checked and recorded inhaler technique, and PEF levels above 75% of best or predicted.

Eczema in Children: Symptoms and Management

Eczema is a common skin condition that affects around 15-20% of children and is becoming more prevalent. It usually appears before the age of 2 and clears up in around 50% of children by the age of 5 and in 75% of children by the age of 10. The symptoms of eczema include an itchy, red rash that can worsen with repeated scratching. In infants, the face and trunk are often affected, while in younger children, it typically occurs on the extensor surfaces. In older children, the rash is more commonly seen on the flexor surfaces and in the creases of the face and neck.

To manage eczema in children, it is important to avoid irritants and use simple emollients. Large quantities of emollients should be prescribed, roughly in a ratio of 10:1 with topical steroids. If a topical steroid is also being used, the emollient should be applied first, followed by waiting at least 30 minutes before applying the topical steroid. Creams are absorbed into the skin faster than ointments, and emollients can become contaminated with bacteria, so fingers should not be inserted into pots. Many brands have pump dispensers to prevent contamination.

In severe cases, wet wrapping may be used, which involves applying large amounts of emollient (and sometimes topical steroids) under wet bandages. Oral ciclosporin may also be used in severe cases. Overall, managing eczema in children involves a combination of avoiding irritants, using emollients, and potentially using topical steroids or other medications in severe cases.

Investigations for Osteoarthritis: When are they necessary?

Osteoarthritis (OA) is a condition that affects synovial joints, resulting in damage to the joints and loss of cartilage, bone remodelling, and osteophyte formation. While any synovial joint can be affected, the most common areas are the hip, knees, and fingers. In individuals over 45 years old with clear signs and symptoms of OA, a clinical diagnosis can be made without the need for investigation.

Typical signs of OA include pain that is activity-related rather than early-morning pain and stiffness, making an inflammatory cause for the symptoms unlikely. While an X-ray may show changes such as reduced joint space and osteophyte formation, it is not necessary to confirm the diagnosis in individuals over 45 years old with typical signs or symptoms. However, an X-ray may be indicated in patients over 55 years old with knee pain following trauma or if the cause of non-traumatic joint pain is unclear from history and examination alone.

Erythrocyte sedimentation rate (ESR) is a non-specific inflammatory marker that may be raised in response to active infection or inflammation. However, it would not be helpful in diagnosing OA unless the diagnosis was unclear and inflammatory conditions needed to be excluded. Similarly, rheumatoid factor, an autoantibody present in patients with rheumatoid arthritis, is unlikely to be present in individuals with OA.

Serum uric acid measurement may be indicated if gout is suspected, as hyperuricaemia can cause gout by forming uric acid crystals in joints. However, gout presents acutely with severe pain, swelling, redness, and heat to the affected joint, unlike the gradual onset of symptoms in OA. Uric acid measurement may be normal during an acute attack and should be checked following resolution of an acute attack.